Actuate Therapeutics (ACTU) Accounts Payables (2023 - 2025)
Actuate Therapeutics (ACTU) posted quarterly Accounts Payables of $1.5 million for Q4 2025, down 20.66% year-over-year from $1.9 million in Q4 2024, and up 22.39% quarter-over-quarter from $1.2 million in Q3 2025.
Actuate Therapeutics (ACTU) Accounts Payables (2023 - 2025) Analysis & Trends
Actuate Therapeutics (ACTU) has reported Accounts Payables for 3 consecutive years, with $1.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Accounts Payables fell 20.66% year-over-year to $1.5 million; the TTM figure through Dec 2025 stood at $1.5 million (down 20.66% YoY), while the FY2025 annual figure was $1.5 million, down 20.66% from the prior year.
- Accounts Payables advanced to $1.5 million in Q4 2025 per ACTU's latest filing, from $1.2 million in the prior quarter.
- Across five years, Accounts Payables topped out at $3.4 million in Q4 2023 and bottomed at $404991.0 in Q2 2024.
- Historically, Accounts Payables has averaged $2.1 million across 3 years, with a median of $2.1 million in 2024.
- On a YoY basis, Accounts Payables climbed as much as 682.98% in 2025 and fell as far as 46.55% in 2025.
- Actuate Therapeutics' Accounts Payables stood at $3.4 million in 2023, then sank by 43.86% to $1.9 million in 2024, then decreased by 20.66% to $1.5 million in 2025.
- Business Quant data shows ACTU's Accounts Payables at $1.5 million in Q4 2025, $1.2 million in Q3 2025, and $3.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Actuate Therapeutics | 30.08 Mn | 30.08 Mn | - | 1.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 1.25 Mn |
| Jun 30, 2025 | 3.17 Mn |
| Mar 31, 2025 | 2.64 Mn |
| Dec 31, 2024 | 1.92 Mn |
| Sep 30, 2024 | 2.33 Mn |
| Jun 30, 2024 | 404,991.00 |
| Dec 31, 2023 | 3.42 Mn |